pharmaphorum

Isomorphic raises $1.2bn for AI drug hunt

Isomorphic Labs' chief executive, Sir Demis Hassabis, delivering his Nobel Prize lecture in 2024. Alphabet-backed start-up Isomorphic Labs has added to the lustre attached to its AI-powered drug ...
CNBC

Isomorphic Labs President: Working hard to create new wave of medicine

Monday - Friday, 08:00 - 11:00 CET | 14:00 - 17:00 HK/SG Max Jaderberg, President of Isomorphic Labs, speaks to CNBC's Ritika Gupta at London Tech Week to discuss the advancement of AI in medicine Got ...
Yahoo Finance

Demis Hassabis on his rush to ‘solve all disease’ and Isomorphic’s new $2.1 billion

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The Hindu

Meet the 23 new Ministers in Tamil Nadu CM Vijay’s expanded Cabinet

The Tamilaga Vettri Kazhagam (TVK) Cabinet, led by Chief Minister C. Joseph Vijay, was expanded on Thursday (May 21, 2026), with the induction of 23 new members, including two Congress MLAs. The ...
Your Story

Isomorphic Labs Raises $2.1 Billion To Scale AI Drug Discovery

The race to use artificial intelligence for designing medicines is rapidly becoming one of the most expensive and closely watched bets in technology and biotech. On 12 May 2026, Isomorphic Labs ...
MobiHealthNews

Google-backed Isomorphic Labs raises $2.1B for AI drug discovery platform

Isomorphic Labs, an AI drug discovery and development company, raised $2.1 billion in a Series B funding round led by Thrive Capital. The raise was also backed by existing investors Alphabet and GV ...
CIOL

Backed By Alphabet, Isomorphic Labs Raises $2.1 Billion To Scale AI Drug Discovery Platform

Isomorphic Labs, the AI-first drug discovery company founded by Demis Hassabis, has raised $2.1 billion in a Series B funding round as competition intensifies around artificial intelligence-driven ...
Forbes

Isomorphic Labs’ $2.1 Billion Fundraise Is The Biggest Bet Yet On AI Drug Discovery

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Demis Hassabis, CEO of Isomorphic and Google DeepMind Isomorphic, which formed as an ...
Reuters

Google-backed Isomorphic raises $2.1 billion to scale AI-driven drug discovery

May 12 (Reuters) - Isomorphic Labs, an artificial intelligence-driven drug discovery company, said on Wednesday it has raised $2.1 billion in its latest funding round led by existing investor Thrive ...
Bloomberg L.P.

DeepMind Spinout Isomorphic Labs Raises $2.1 Billion to Design Drugs With AI

Alphabet Inc.’s Isomorphic Labs raised $2.1 billion in its second round of outside capital, with new support from sovereign wealth funds, as it seeks to make artificial intelligence-designed drugs a ...
FierceBiotech

Alphabet's AI biotech Isomorphic Labs bags $2.1B series B to fuel next-gen drug design model

If any proof was needed that big money is still available for AI drug development, look no further than the ten-figure series B hauled in by Isomorphic Labs. The London-based AI drug discovery firm ...